Inspire Pharmaceuticals' stock price fell 13.4% after the company announced a delay in the submission of its drug application to the FDA.
Drug developer Inspire Pharmaceuticals Inc . ( nasdaq : ISPH - news - people ) tumbled $ 2.17 , or 13.4 percent , to $ 13.98 .